护士实施丙泊酚镇静在门诊胃肠镜患者中的安全性与有效性
该研究连续纳入2006年1月至2016年12月接受诊断性食管胃十二指肠镜(n=117,661)或结肠镜(n=32,550)丙泊酚镇静的门诊患者(年龄20-98岁),由护士按年龄调整标准方案单次静脉推注丙泊酚,总量不超过200 mg。主要结局为24小时内不良事件;食管胃十二指肠镜中位剂量77 mg(范围20-160 mg),结肠镜99 mg(范围40-200 mg);唯一不良事件为需短暂补充供氧,共1950例(1.3%)。作者认为该方案安全可行。
要点
- 护士按年龄调整方案推注丙泊酚,总量不超过200 mg,用于门诊胃肠镜。
- 食管胃十二指肠镜中位剂量77 mg,结肠镜中位剂量99 mg。
- 唯一不良事件为短暂需补充供氧,共1950例(1.3%)。
核心结论
- 护士按年龄调整标准方案实施丙泊酚单药镇静、总量不超过200 mg,对门诊胃肠镜安全且可行。
研究设计与样本
- 连续纳入2006年1月至2016年12月接受诊断性食管胃十二指肠镜(n=117,661)或结肠镜(n=32,550)丙泊酚镇静的门诊患者(年龄20-98岁)。
- 丙泊酚由护士经单次静脉推注给药,采用年龄调整标准方案,总量不超过200 mg。
- 主要结局为24小时内不良事件;次要结局包括操作成功率、呼吸抑制及其他操作相关不良事件。
主要发现
- 食管胃十二指肠镜丙泊酚中位剂量77 mg(范围20-160 mg),结肠镜中位剂量99 mg(范围40-200 mg)。
- 食管胃十二指肠镜患者中,41岁以下者所需丙泊酚为61-80岁者的1.5倍。
- 唯一不良事件为短暂需补充供氧,共1950例(1.3%):食管胃十二指肠镜1689例(1.4%),结肠镜261例(0.8%)。
- 患者在60分钟后离院,至少66,250例(44%)自行驾车离开医院,24小时内均未发生交通事故。
临床怎么用
- 作者认为护士按年龄调整标准方案实施丙泊酚单药镇静、总量不超过200 mg,对门诊胃肠镜安全且可行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Esophagogastroduodenoscopy (EGD) and colonoscopy are common outpatient gastrointestinal endoscopic procedures that frequently use sedation. We aimed to identify a protocol that combines safety with cost effectiveness. METHODS: We collected data from consecutive outpatients (age, 20-98 y) who underwent diagnostic EGD (n = 117,661) or colonoscopy (n = 32,550) with propofol sedation from January 2006 through December 2016. Propofol was administered by a nurse via bolus injection using an age-adjusted standard protocol, up to a total of 200 mg. The primary outcome measure was occurrence of adverse events within 24 hours. Secondary outcome measures included rates of procedure success, respiratory depression, and other procedure-related adverse events. RESULTS: The median dose of propofol administered for EGD was 77 mg (range, 20-160 mg) and for colonoscopy was 99 mg (range, 40-200 mg). Among patients undergoing EGD, those younger than 41 years required 1.5-fold more propofol than patients 61-80 years old. The only adverse event was the transient need for supplemental oxygen supply, required by 1950 patients (1.3%): 1689 undergoing EGD (1.4%) and 261 undergoing colonoscopy (0.8%). Patients were discharged after 60 minutes and at least 66,250 patients (44%) drove themselves from the hospital. None experienced a traffic accident within 24 hours after receiving propofol sedation. CONCLUSIONS: Nurse-administered propofol monosedation using an age-adjusted standard protocol up to a maximal of 200 mg is safe and practical for outpatient gastrointestinal endoscopy.
引用
- Sato M, Horiuchi A, Tamaki M, et al. Safety and Effectiveness of Nurse-Administered Propofol Sedation in Outpatients Undergoing Gastrointestinal Endoscopy. Clin Gastroenterol Hepatol. 2018. PMID: 29933097. doi:10.1016/j.cgh.2018.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。